Real-world efficacy and safety of first-line nivolumab plus chemotherapy in patients with advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: A nationwide observational Turkish Oncology Group (TOG) study için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Real-world efficacy and safety of first-line nivolumab plus chemotherapy in patients with advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: A nationwide observational Turkish Oncology Group (TOG) study | 1 |
Aylık toplam ziyaret
| views | |
|---|---|
| Aralık 2025 | 0 |
| Ocak 2026 | 0 |
| Şubat 2026 | 0 |
| Mart 2026 | 0 |
| Nisan 2026 | 1 |
| Mayıs 2026 | 0 |
| Haziran 2026 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| Kutlu-Yasin-2024.pdf | 2 |
